Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for building hepatitis B e-antigen negative mouse model

A hepatitis B, mouse model technology, applied in the field of genetic engineering

Inactive Publication Date: 2017-06-20
CHONGQING MEDICAL UNIVERSITY +1
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the current research on chronic HBV infection and treatment is mainly based on e-positive animal models. So far, there is no research and report on e-negative HBV infection animal models in the world. The current research on e-negative HBV infection Limited to pathogenesis, drug management, and drug screening

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for building hepatitis B e-antigen negative mouse model
  • Method for building hepatitis B e-antigen negative mouse model
  • Method for building hepatitis B e-antigen negative mouse model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment one, construct the mouse model of hepatitis B e antigen negative

[0039] Follow the steps below:

[0040] 1. Cloning of full-length DNA of HBV e-negative virus strain

[0041] 1. Amplify the full length of HBV DNA: extract the DNA from the serum of patient No. 11061008 (provided by the Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University) diagnosed as HBeAg-negative infection, and use primers to perform PCR amplification of HBV-F / HBV-R , the primer sequence is:

[0042] Upstream primer HBV-F:

[0043] 5'-CCGGAAAGCTTATGCTCTTCTTTTTCACCTCTGCCTARTCATC-3',

[0044] Downstream primer HBV-R:

[0045] 5'-CCGGAGAGCTCATGCTCTTCAAAAAGTTGCATGGTGCTGGTG-3'.

[0046] 2. Sequence the PCR product obtained in step 1 to obtain its sequence, redesign the primers according to the sequencing results, delete 7 bases in the newly designed upstream and downstream primers, and change the degenerate bases of the upstream primers accordi...

Embodiment 2

[0056] Embodiment two, the detection of mouse model

Embodiment 1

[0057] Detect the experimental group, control group, and blank group mouse models constructed in Example 1:

[0058] 1. Detection of HBV-specific markers in mouse serum

[0059] Specific markers of HBV such as HBsAg, HBeAg, viral DNA, and alanine aminotransferase (ALT) were detected in the serum of experimental mice at different time points. The detection of HBsAg and HBeAg was performed using a radioimmunoassay kit; the detection of ALT was performed using a small Mouse ELISA Kit.

[0060] The real-time fluorescent quantitative PCR method was used for the detection of HBV DNA. 50 μL serum was taken for extraction of viral DNA and RNA, 2 μL total DNA was used for qPCR, and the HBV copy number was analyzed. Primers were designed and amplified in the conserved region of the HBV gene, forward primer: HBV-Q-F: 5′-CCTCTTCATCCTGCTGCT-3′; reverse primer HBV-Q-R: 5′-AACTGAAAGCCAAACAGTG-3′, the standard curve uses pEASY-HBV / HBeAg-negative HBVDNA by 5×10 3 ,5×10 4 ,5×10 5 ,5×10 6...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for building a hepatitis B e-antigen negative mouse model. The method comprises the following steps: 1) extracting serum DNA of a patient diagnosed with HBeAg negative HBV infection, and carrying out PCR amplification by using a primer pair HBV-F / HBV-R; 2) sequencing a PCR product, and redesigning a specific PCR amplification primer pair to the sequence for PCR amplification; 3) cloning the PCR product to a pEASY-Blunt Zero carrier; 4) extracting plasmids, carrying out enzyme digestion, recovering and purifying fragments, and carrying out cyclization and purification to obtain HBVe negative cccDNA; and 5) injecting the cccDNA into a mouse, thereby building the hepatitis B e-antigen negative mouse model. According to the invention, the hepatitis B e-antigen negative mouse model is successfully built for the first time, which is highly significant for study on the mechanism of the HBeAg negative hepatitis infection and study on medication effects.

Description

technical field [0001] The invention belongs to the field of genetic engineering, and in particular relates to a method for constructing a hepatitis B e antigen-negative mouse model. Background technique [0002] Viral hepatitis B is a major global health problem caused by hepatitis B virus (HBV). Chronic hepatitis B caused by HBV infection may develop into cirrhosis and hepatocellular carcinoma. Recently, it was reported that about 248 million people in the world suffer from chronic hepatitis B (CHB). The serological classification of chronic hepatitis B is very complicated. According to the level of serum e antigen, it can be divided into e antigen positive and e antigen negative chronic hepatitis B infection. In recent years, the number of HBV infections in the world has decreased, but the number of HBeAg-negative infections is increasing. However, the current response rate to antiviral therapy for e-antigen-negative patients is low, resulting in increased processing t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N15/85A01K67/027
CPCC12N15/8509A01K67/0278A01K2207/15A01K2217/05A01K2227/105A01K2267/0337
Inventor 赖国旗张华堂赵中华王蕾曹敏魏青绿向钦唐雨微
Owner CHONGQING MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com